Cytomegalovirus prophylaxis with IV ganciclovir in lung transplant recipients: The long and the short of it!

Chest

Volumn 116, Issue 5, 1999, Pages 1152-1153

  Orens, J B ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR;

ANTIBIOTIC PROPHYLAXIS; BRONCHIOLITIS; CYTOMEGALOVIRUS INFECTION; EDITORIAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INTRAVENOUS DRUG ADMINISTRATION; LUNG TRANSPLANTATION; PRIORITY JOURNAL;

EID: 0032718080     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.116.5.1152     Document Type: Editorial

References (5)

1. NA Ettinger TC Baily EP Trulock Cytomegalovirus infection and pneumonitis: impact after isolated lung transplantation Am Rev Respir Dis 147 1993 1017 1023
2. D Heng LD Sharples K McNeil Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors J Heart Lung Transplant 17 1998 1255 1263
3. JD Hosenpud LE Bennett BM Keck The registry of the international society for heart and lung transplantation: sixteenth official report; 1999 J Heart Lung Transplant 18 1999 611 626
4. SR Duncan IL Paradis JH Dauber Ganciclovir prophylaxis for cytomegalovirus infections in pulmonary allograft recipients Am Rev Respir Dis 146 1992 1213 1215
5. HA Valantine Prevention and treatment of cytomegalovirus disease in thoracic organ transplant patients: evidence for a beneficial effect of hyperimmune globulin Transplant Proc 27 1995 49 57